ClosedPublished 11 Feb 2025

Immedica Pharma AB /
Marinus Pharmaceuticals, Inc.

Immedica completes acquisition of Marinus Pharmaceuticals, Inc.

Buy side: Immedica Pharma AB
Buy sideImmedica Pharma AB
Target: Marinus Pharmaceuticals, Inc.
TargetMarinus Pharmaceuticals, Inc.
Source · 11 Feb 2025Source-verified
Buy side: Immedica Pharma AB
Buy sideImmedica Pharma AB
Target: Marinus Pharmaceuticals, Inc.
TargetMarinus Pharmaceuticals, Inc.
01 / BuyerImmedica Pharma AB
02 / TargetMarinus Pharmaceuticals, Inc.
Source-verified
01

What happened

Immedica Pharma AB completed its acquisition of Marinus Pharmaceuticals, Inc. on Feb. 11, 2025, through its indirect wholly owned subsidiary Matador Subsidiary, Inc. Marinus became an indirect wholly owned subsidiary of Immedica.

The aggregate consideration was approximately $32.3 million, excluding related transaction fees and expenses.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Immedica completes acquisition of Marinus Pharmaceuticals, Inc.

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.